
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg.".
Filed with NSE · · 2 pages · English

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg.".
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals